NASDAQ: LSTA LISATA THERAPEUTICS, INC. 8-K

Lisata merger delayed as Kuva Labs pushes tender offer deadline to May 29

Filed May 4, 2026 · Period ending May 3, 2026 · ~1 min read

Key Changes

  • high

    Kuva Labs extended the deadline to launch its tender offer for Lisata shares from April 13 to May 29, 2026, with possibility of further delays by mutual agreement. The six-week extension suggests the buyer needs more time to satisfy closing conditions or secure financing.

  • high

    Lisata waived its right to sue Kuva Labs for missing the original April 13 deadline, giving up legal recourse for the delay once the tender offer launches and expense payments are made. The waiver can only be revoked if Kuva fails to pay agreed expenses or materially breaches the amendment.

  • medium

    Kuva Labs will reimburse Lisata up to $1.1 million for expenses incurred during the extended merger timeline, helping cover operational costs while shareholders wait for the deal to close.

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.

Partner

Trade LSTA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 10, 2026 11:33 PM